SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-129481
Filing Date
2021-10-25
Accepted
2021-10-25 16:01:19
Documents
18
Period of Report
2021-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2130533d6_8k.htm   iXBRL 8-K 36152
2 EXHIBIT 1.1 tm2130533d6_ex1-1.htm EX-1.1 197374
3 EXHIBIT 5.1 tm2130533d6_ex5-1.htm EX-5.1 11280
4 EXHIBIT 99.1 tm2130533d6_ex99-1.htm EX-99.1 11258
8 GRAPHIC tm2130533d6_ex5-1img001.jpg GRAPHIC 5266
9 GRAPHIC tm2130533d6_ex5-1img002.jpg GRAPHIC 16982
10 GRAPHIC tm2130533d6_ex99-1img001.jpg GRAPHIC 6732
  Complete submission text file 0001104659-21-129481.txt   527712

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA isee-20211021.xsd EX-101.SCH 3195
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE isee-20211021_lab.xml EX-101.LAB 34594
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isee-20211021_pre.xml EX-101.PRE 22717
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2130533d6_8k_htm.xml XML 3600
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 211344212
SIC: 2834 Pharmaceutical Preparations